Related news from
Sun, 05 May 2024 12:08:19 +0000	Earnings Beat: Sarepta Therapeutics, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models Sarepta Therapeutics, Inc. ( NASDAQ:SRPT ) just released its quarterly report and things are looking bullish. It was a...
Fri, 03 May 2024 14:07:00 +0000	Gene Therapy Pioneer Jerry R. Mendell, M.D., Named to Inaugural TIME100 Health List of the 100 Most Influential People in Global Health CAMBRIDGE, Mass., May 03, 2024--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that TIME named renown neuromuscular researcher, physician and gene therapy pioneer Jerry R. Mendell, M.D., to the inaugural 2024 TIME100 Health, a list of 100 individuals who most influenced global health this year. Dr. Mendell was recognized for his lifetime commitment to neuromuscular disease and achievements in genetic medicine that propelled a
Thu, 02 May 2024 19:42:59 +0000	Sarepta Therapeutics to Benefit as Regulatory Review on DMD Therapy Picks Up, Morgan Stanley Says Sarepta Therapeutics to Benefit as Regulatory Review on DMD Therapy Picks Up, Morgan Stanley Says
Thu, 02 May 2024 15:13:00 +0000	Sarepta (SRPT) Q1 Earnings Beat Estimates, Revenues Up Y/Y Sarepta (SRPT) reports better-than-expected Q1 earnings on the back of strong sales for recently-approved DMD gene therapy Elevidys.
Thu, 02 May 2024 15:08:54 +0000	Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Q1 2024 Earnings Call Transcript Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Q1 2024 Earnings Call Transcript May 1, 2024 Sarepta Therapeutics, Inc. beats earnings expectations. Reported EPS is $0.37, expectations were $-0.11. Sarepta Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon and welcome […]
Thu, 02 May 2024 10:01:08 +0000	Q1 2024 Sarepta Therapeutics Inc Earnings Call Q1 2024 Sarepta Therapeutics Inc Earnings Call
Thu, 02 May 2024 07:32:54 +0000	Sarepta Therapeutics Inc (SRPT) Q1 2024 Earnings Call Transcript Highlights: Robust Revenue ... Discover key insights from Sarepta Therapeutics' Q1 2024 earnings, including significant revenue increases and promising developments in drug approvals and market expansions.
Wed, 01 May 2024 23:30:14 +0000	Sarepta Therapeutics (SRPT) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates Although the revenue and EPS for Sarepta Therapeutics (SRPT) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Wed, 01 May 2024 23:30:13 +0000	Sarepta Therapeutics (SRPT) Q1 2024 Earnings Call Transcript SRPT earnings call for the period ending March 31, 2024.
Wed, 01 May 2024 21:20:06 +0000	Sarepta Therapeutics (SRPT) Q1 Earnings and Revenues Beat Estimates Sarepta Therapeutics (SRPT) delivered earnings and revenue surprises of 763.64% and 10.91%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Wed, 01 May 2024 20:05:00 +0000	Sarepta Therapeutics Announces First Quarter 2024 Financial Results and Recent Corporate Developments CAMBRIDGE, Mass., May 01, 2024--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today reported financial results for the first quarter 2024.
Wed, 01 May 2024 13:15:00 +0000	1 Top Growth Stock to Buy and Hold for 10 Years This company's lineup might look very different in a decade, but the end result will be the same for investors.
Tue, 30 Apr 2024 22:38:00 +0000	Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) CAMBRIDGE, Mass., April 30, 2024--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, granted equity awards on April 30, 2024 that were previously approved by the Compensation Committee of its Board of Directors under Sarepta’s 2024 Employment Commencement Incentive Plan, as a material inducement to employment to 24 individuals hired by Sarepta in April 2024. The equity awards were approved in accordance with Nasdaq Listing Rule 5635(c)(4).
Tue, 30 Apr 2024 13:28:00 +0000	Why Sarepta (SRPT) Might Surprise This Earnings Season Sarepta (SRPT) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Mon, 29 Apr 2024 19:20:00 +0000	Sarepta Therapeutics Stock Shows Improved Technical Strength A Relative Strength Rating upgrade for Sarepta Therapeutics shows improving technical performance. Will it continue?
Fri, 26 Apr 2024 13:00:09 +0000	How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Thu, 25 Apr 2024 14:02:05 +0000	Analysts Estimate Amgen (AMGN) to Report a Decline in Earnings: What to Look Out for Amgen (AMGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Thu, 25 Apr 2024 13:55:05 +0000	Bullish Sarepta Therapeutics Insiders Loaded Up On US$13.3m Of Stock Multiple insiders secured a larger position in Sarepta Therapeutics, Inc. ( NASDAQ:SRPT ) shares over the last 12...
Wed, 24 Apr 2024 12:30:00 +0000	Sarepta Therapeutics to Announce First Quarter 2024 Financial Results CAMBRIDGE, Mass., April 24, 2024--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, will report first quarter 2024 financial results after the Nasdaq Global Market closes on Wednesday, May 1, 2024. Subsequently, at 4:30 p.m. E.T., the Company will host a conference call to discuss its first quarter 2024 financial results.
Sun, 14 Apr 2024 01:39:18 +0000	10 Unstoppable Stocks That Will Make You Richer In this article, we discuss the 10 unstoppable stocks that will make you richer. To skip the detailed analysis of the economy and market, go directly to the 5 Unstoppable Stocks That Will Make You Richer. On April 12, the week closed out with stocks tumbling as the S&P 500 recorded its worst day since […]